These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 957902

  • 1. A comparison of the effects of decarboxylase inhibitors on L-dopa-induced circling behavior and the conversion of dopa to dopamine in the brain.
    Goodale DB, Moore KE.
    Life Sci; 1976 Sep 01; 19(5):701-6. PubMed ID: 957902
    [No Abstract] [Full Text] [Related]

  • 2. The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-rats.
    Treseder SA, Rose S, Jenner P.
    Eur J Neurosci; 2001 Jan 01; 13(1):162-70. PubMed ID: 11135014
    [Abstract] [Full Text] [Related]

  • 3. [Effect of VB6 on L-DOPA decarboxylase activity in the organs of rats given peripheral L-DOPA decarboxylase inhibitors (author's transl)].
    Yoshimine N, Kuzuya F, Mori K, Sakamoto N.
    Nihon Ronen Igakkai Zasshi; 1978 Nov 01; 15(6):566-73. PubMed ID: 732010
    [No Abstract] [Full Text] [Related]

  • 4. Benserazide decreases central AADC activity, extracellular dopamine levels and levodopa decarboxylation in striatum of the rat.
    Jonkers N, Sarre S, Ebinger G, Michotte Y.
    J Neural Transm (Vienna); 2001 Nov 01; 108(5):559-70. PubMed ID: 11459076
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
    Da Prada M, Kettler R, Zürcher G, Schaffner R, Haefely WE.
    Eur Neurol; 1987 Nov 01; 27 Suppl 1():9-20. PubMed ID: 3123242
    [Abstract] [Full Text] [Related]

  • 6. Suppression of L-dopa-induced circling in rats with nigral lesions by blockade of central dopa-decarboxylase: implications for mechanism of action of L-dopa in parkinsonism.
    Melamed E, Hefti F, Bitton V, Globus M.
    Neurology; 1984 Dec 01; 34(12):1566-70. PubMed ID: 6504328
    [Abstract] [Full Text] [Related]

  • 7. Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolites.
    Alachkar A, Brotchie JM, Jones OT.
    Neurosci Res; 2010 Sep 01; 68(1):44-50. PubMed ID: 20542064
    [Abstract] [Full Text] [Related]

  • 8. In vivo assessment of decarboxylase inhibition or potentiation: urinary dopamine and L-dopa output after L-dopa administration.
    Johnson RD, Ruthven CR, Goodwin BL, Sandler M.
    J Neural Transm; 1976 Sep 01; 38(3-4):181-91. PubMed ID: 956809
    [Abstract] [Full Text] [Related]

  • 9. The effect of L-dopa and an inhibitor of peripheral decarboxylation on glucose metabolism in brain.
    Tyce GM.
    J Neurochem; 1976 Dec 01; 27(6):1397-403. PubMed ID: 1003214
    [No Abstract] [Full Text] [Related]

  • 10. The timing of administration, dose dependence and efficacy of dopa decarboxylase inhibitors on the reversal of motor disability produced by L-DOPA in the MPTP-treated common marmoset.
    Tayarani-Binazir KA, Jackson MJ, Fisher R, Zoubiane G, Rose S, Jenner P.
    Eur J Pharmacol; 2010 Jun 10; 635(1-3):109-16. PubMed ID: 20303948
    [Abstract] [Full Text] [Related]

  • 11. The pharmacology of Parkinson's disease: basic aspects and recent advances.
    Da Prada M, Keller HH, Pieri L, Kettler R, Haefely WE.
    Experientia; 1984 Nov 15; 40(11):1165-72. PubMed ID: 6437857
    [Abstract] [Full Text] [Related]

  • 12. Protective effects of L-dopa and carbidopa combined treatments on human catecholaminergic cells.
    Colamartino M, Padua L, Meneghini C, Leone S, Cornetta T, Testa A, Cozzi R.
    DNA Cell Biol; 2012 Nov 15; 31(11):1572-9. PubMed ID: 23020119
    [Abstract] [Full Text] [Related]

  • 13. L-DOPA exacerbates amphetamine-induced dopamine depletion.
    Myers CS, Witten M, Yu YL, Wagner GC.
    Mol Chem Neuropathol; 1998 Feb 15; 33(2):81-97. PubMed ID: 9565967
    [Abstract] [Full Text] [Related]

  • 14. A comparison of the effects of reversible and irreversible inhibitors of aromatic L-amino acid decarboxylase on the half-life and other pharmacokinetic parameters of oral L-3,4-dihydroxyphenylalanine.
    Huebert ND, Palfreyman MG, Haegele KD.
    Drug Metab Dispos; 1983 Feb 15; 11(3):195-200. PubMed ID: 6135575
    [Abstract] [Full Text] [Related]

  • 15. Aterial blood pressure in dogs: effects of m-tyrosine alone or in combination with inhibitors of aromatic amino acid decarboxylase; relative hypotensive potencies of L-dopa, DL-m-tyrosine, and L-m-tyrosine.
    Minsker DH, Stokes AL.
    Experientia; 1974 Sep 15; 30(9):1051-3. PubMed ID: 4412113
    [No Abstract] [Full Text] [Related]

  • 16. L-Dopa inhibits prolactin secretion in proestrous rats.
    Wiggins JF, Fernstrom JD.
    Endocrinology; 1977 Aug 15; 101(2):469-74. PubMed ID: 560295
    [Abstract] [Full Text] [Related]

  • 17. In vivo antagonism of the behavioral responses to L-3-,4-dihydroxyphenylalanine by L-3-,4-dihydroxyphenylalanine cyclohexyl ester in conscious rats.
    Matsushita N, Misu Y, Goshima Y.
    Eur J Pharmacol; 2009 Mar 01; 605(1-3):109-13. PubMed ID: 19168057
    [Abstract] [Full Text] [Related]

  • 18. Modulatory effects of L-DOPA on D2 dopamine receptors in rat striatum, measured using in vivo microdialysis and PET.
    Opacka-Juffry J, Ashworth S, Ahier RG, Hume SP.
    J Neural Transm (Vienna); 1998 Mar 01; 105(4-5):349-64. PubMed ID: 9720967
    [Abstract] [Full Text] [Related]

  • 19. Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.
    Pinder RM, Brogden RN, Sawyer PR, Speight TM, Avery GS.
    Drugs; 1976 Mar 01; 11(5):329-77. PubMed ID: 782834
    [No Abstract] [Full Text] [Related]

  • 20. Dose and sex related effects of aromatic aminoacids decarboxylase inhibitors on serum prolactin in humans.
    Polleri A, Masturzo P, Murialdo G, Carolei A.
    Acta Endocrinol (Copenh); 1980 Jan 01; 93(1):7-12. PubMed ID: 7355667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.